Cn / En

CM05186


CM05186

Key word胰腺癌, PDX, 体内药效,体外药效,免疫系统人源化,奥拉帕利, 奥沙利铂, 奥希替尼, 厄洛替尼, 吉西他滨, 曲美替尼, 顺铂, 依维莫司, 长春新碱, 紫杉醇,Sacituzumab Tirumotecan,

Model Information

Model IDCM05186
Cancer Type胰腺癌
Cell Subtype腺癌
Differentiation中分化
Collection SiteHead
Metastatic Site 
Grade 
TNM stagingypTxNxMx
IHC diagnosis肝肿瘤免疫组化标记结果 CAM5.2(+) CgA(+) CK19(+) Syn(+) CA19-9(+) Islet-1(少) MUC-5(-)P53(70%) NSE(-)Ki-67(70%)
Pathology diagnosis(胰头)中分化导管腺癌,符合新辅助化疗后肿瘤中等反应,?? TRG
Clinical Treatment Records 

Model Data

Histopathological Images

 

Tumor growth curve

  

In vivo efficacy of SOCs

  
  
  

In vitro efficacy of SOCs